Literature DB >> 20010922

Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults.

Chien-Yu Lin1, Lian-Yu Lin, Chih-Kang Chiang, Wei-Jie Wang, Yi-Ning Su, Kuan-Yu Hung, Pau-Chung Chen.   

Abstract

OBJECTIVES: Perfluorinated chemicals (PFCs) have been largely used for years in a variety of products worldwide. However, the toxic effect of PFCs on exposure to the liver in the general population has not yet been determined.
METHODS: In this study, 2,216 adults (18 years of age or older) were recruited in a National Health and Nutrition Examination Survey (NHANES) in 1999-2000 and 2003-2004 to determine the relationship between serum level of PFCs and the levels of liver enzymes. The data were adjusted for all other confounding variants.
RESULTS: After performing mathematical analysis, we determined when serum log-perfluorooctanoic acid (PFOA) increases in one unit, the serum alanine aminotransferase (ALT) concentration (U/l) increases by 1.86 units (95% confidence interval (CI), 1.24-2.48; P=0.005), and the serum log-gamma-glutamyltransferase (GGT) concentration (U/l) is 0.08 unit higher (95% CI, 0.05-0.11; P=0.019). The association between PFOA and liver enzymes was more evident in obese subjects, as well as subjects with insulin resistance and/or metabolic syndromes. When dividing the serum PFOA into quartiles in the fully adjusted models in subjects with a body mass index>or=30 kg/m2, the ALT level trend across the serum PFOA quartiles was significant (P=0.003).
CONCLUSIONS: On the basis of these data, we conclude that a higher serum concentration of PFOA may cause liver enzymes to increase abnormally in the general population, particularly in obese individuals. Further studies are warranted to clarify the casual relationship between PFCs and these liver enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20010922     DOI: 10.1038/ajg.2009.707

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  36 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.

Authors:  Yu-Li Chen; Ming-Cheng Chang; Chia-Yen Huang; Ying-Cheng Chiang; Han-Wei Lin; Chi-An Chen; Chang-Yao Hsieh; Wen-Fang Cheng
Journal:  Mol Oncol       Date:  2011-12-20       Impact factor: 6.603

3.  Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.

Authors:  Kelsey E Barton; Anne P Starling; Christopher P Higgins; Carrie A McDonough; Antonia M Calafat; John L Adgate
Journal:  Int J Hyg Environ Health       Date:  2019-08-20       Impact factor: 5.840

4.  Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.

Authors:  Kim E Innes; Alan M Ducatman; Michael I Luster; Anoop Shankar
Journal:  Am J Epidemiol       Date:  2011-06-27       Impact factor: 4.897

5.  Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability.

Authors:  Yong Qian; Alan Ducatman; Rebecca Ward; Steve Leonard; Valerie Bukowski; Nancy Lan Guo; Xianglin Shi; Val Vallyathan; Vincent Castranova
Journal:  J Toxicol Environ Health A       Date:  2010

6.  Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs) in humans: the NOWAC postgenome study.

Authors:  Charlotta Rylander; Vanessa Dumeaux; Karina Standahl Olsen; Marit Waaseth; Torkjel M Sandanger; Eiliv Lund
Journal:  Int J Mol Epidemiol Genet       Date:  2011-06-03

7.  A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes.

Authors:  Cuilin Zhang; Rajeshwari Sundaram; José Maisog; Antonia M Calafat; Dana Boyd Barr; Germaine M Buck Louis
Journal:  Fertil Steril       Date:  2014-10-22       Impact factor: 7.329

Review 8.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

9.  Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines.

Authors:  John Bassler; Alan Ducatman; Meenal Elliott; Sijin Wen; Banrida Wahlang; John Barnett; Matthew C Cave
Journal:  Environ Pollut       Date:  2019-01-18       Impact factor: 8.071

Review 10.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.